LYCOS RETRIEVER 
Trial: Avicena Group
built 388 days ago
Approximately 45 subjects will be enrolled in the trial. Subjects will be randomized to one of two groups in a 2:1 ratio. The larger group (approximately 30 subjects) will be treated by intramuscular injection of 60 mg of SB-509 (30 mg of SB-509 per leg) into the lower limb every 3 months. The remaining group (approximately 15 subjects) will receive an equal volume of placebo on the same schedule. Each subject will receive a total of two treatments (Day 0 and 90). Subjects will receive injections in a distribution pattern that targets the major peripheral nerves in the legs and feet.
Source:
EINDHOVEN, The Netherlands, October 18/PRNewswire-FirstCall/ -- The city of Caen in Normandy, France will today be the setting for a trial of one of the most promising new technologies in the mobile telecommunications market: Near Field Communication (NFC). With this touch-based technology from Royal Philips Electronics (NYSE: PHG, AEX: PHI), 200 Caen residents will use mobile phones with an embedded Philips NFC chip as a means of secure payment in selected retail stores, parking facilities and famous tourist sites around town in a six-month trial. For the trial, Philips will work closely with France Telecom R&D, network operator Orange, handset manufacturer Samsung and renowned retailers Groupe LaSer and Vinci Park.
Source:
The trial was conducted at the Beijing Sino-Japan Friendship Hospital in Beijing using a double-blind, randomized method of testing on 120 volunteers. The volunteers were divided into four groups of 30 persons each, of which 24 were inoculated with the pandemic influenza vaccine and the other six with a placebo. Vaccine safety was documented through blood routing tests, blood biochemistry tests, urine routing tests, and systemic observation of localized events. The preliminary result shows that Sinovac's vaccine is safe for humans; no serious adverse events occurred to any volunteers.
Source:
As president of The Singer Companies, Dr. Singer leads one of the most experienced and successful jury research, trial preparation, and settlement planning and support groups in the country. This multidisciplinary team is comprised of:
Source:
MORE ABOUT
Avicena Group